Acute lung injury is a frequent and treatment-limiting consequence of therapy with hyperoxic gas mixtures. To determine if IL-11 is protective in oxygen toxicity, we compared the effects of 100% O2 on transgenic mice that overexpress IL-11 in the lung and transgene (-) controls. IL-11 markedly enhanced survival in 100% O2 with 100% of transgene (-) animals dying within 72-96 h and > 90% of transgene (+) animals surviving for more than 10 d. This protection was associated with markedly diminished alveolar-capillary protein leak, endothelial and epithelial membrane injury, lipid peroxidation, and pulmonary neutrophil recruitment. Significant differences in copper zinc superoxide dismutase and catalase activities were not noted and the levels of total, reduced and oxidized glutathione were similar in transgene (+) and (-) animals. Glutathione reductase, glutathione peroxidase, and manganese superoxide dismutase activities were slightly higher in transgene (+) as versus (-) mice after 100% O2 exposure, and IL-11 diminished hyperoxia-induced expression of IL-1 and TNF. Hyperoxia also caused cell death with DNA fragmentation in the lungs of transgene (-) animals and IL-11 markedly diminished this cell death response. These studies demonstrate that IL-11 markedly diminishes hyperoxic lung injury. They also demonstrate this protection is associated with small changes in lung antioxidants, diminished hyperoxia-induced IL-1 and TNF production, and markedly suppressed hyperoxia-induced DNA fragmentation.
A B Waxman, O Einarsson, T Seres, R G Knickelbein, J B Warshaw, R Johnston, R J Homer, J A Elias
Title and authors | Publication | Year |
---|---|---|
Hyperoxia and Lungs: What We Have Learned From Animal Models
L Amarelle, L Quintela, J Hurtado, L Malacrida |
Frontiers in Medicine | 2021 |
Therapeutic Targeting of IL-11 for Chronic Lung Disease
RK Kortekaas, JK Burgess, R van Orsoy, D Lamb, M Webster, R Gosens |
Trends in Pharmacological Sciences | 2021 |
Protocol and statistical analysis plan for the Pragmatic Investigation of optimaL Oxygen Targets (PILOT) clinical trial
MW Semler, JD Casey, BD Lloyd, PG Hastings, M Hays, M Roth, J Stollings, J Brems, KG Buell, L Wang, CJ Lindsell, RE Freundlich, JP Wanderer, GR Bernard, WH Self, TW Rice |
BMJ Open | 2021 |
IL-11 mediates the Radioresistance of Cervical Cancer Cells via the PI3K/Akt Signaling Pathway
R Sun, C Chen, X Deng, F Wang, S Song, Q Cai, J Wang, T Zhang, M Shi, Q Ke, Z Luo |
Journal of Cancer | 2021 |